Morphosys (MOR) has released an update.
MorphoSys AG has announced a significant change in major holdings, with Kynam Global Healthcare Master Fund, LP now owning 10.61% of the company’s voting rights as of April 15, 2024. This marks a substantial increase from the previous notification when the fund held 5.33% of the voting rights. The notification was made in compliance with the German Securities Trading Act, indicating a noteworthy shift in share distribution within the company.
For further insights into MOR stock, check out TipRanks’ Stock Analysis page.
